Does RESLIZUMAB Cause Off label use? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Off label use have been filed in association with RESLIZUMAB (CINQAIR). This represents 1.5% of all adverse event reports for RESLIZUMAB.
9
Reports of Off label use with RESLIZUMAB
1.5%
of all RESLIZUMAB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Off label use From RESLIZUMAB?
Of the 9 reports, 1 (11.1%) resulted in death.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RESLIZUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does RESLIZUMAB Cause?
Dyspnoea (86)
Asthma (82)
Drug ineffective (80)
Incorrect dose administered (63)
Hypertension (47)
Headache (41)
Wheezing (40)
Cough (36)
Oropharyngeal pain (31)
Fatigue (29)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RESLIZUMAB Alternatives Have Lower Off label use Risk?
RESLIZUMAB vs RESMETIROM
RESLIZUMAB vs RESTASIS
RESLIZUMAB vs RETINOL
RESLIZUMAB vs REVATIO
RESLIZUMAB vs REVEFENACIN